OptimizeRx Corporation Common Stock (NASDAQ: OPRX) last traded at $7.71, down 3.14% on the session. The quote above updates while this page is open; the figures below are drawn from OptimizeRx Corporation Common Stock’s own filings and are restated only when a new one is published.
OptimizeRx Corporation Common Stock trades on NASDAQ under the ticker OPRX. Its market capitalisation is $145.23 million.
Valuation measures for OptimizeRx Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $145.23M |
|---|---|
| Enterprise value | $154.36M |
| P/E ratio | 32.13 |
| Price / sales | 1.47 |
| Price / book | 1.11 |
| Beta | 2.03 |
Trailing-twelve-month figures tagged in OptimizeRx Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $98.65M |
|---|---|
| Net income (TTM) | $4.60M |
| EPS (TTM) | $0.240 |
| Gross margin | 74.60% |
| Operating margin | 11.04% |
| Return on equity | 3.51% |
| Cash | $24.10M |
Range and volume for OPRX over the past 52 weeks.
| 52-week high | $22.25 |
|---|---|
| 52-week low | $4.54 |
| Volume | 130.7K |
| Average volume | 340.9K |
| Previous close | $7.96 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.